UBS Group’s Xylem XYL Stock Holding History

UBS Group’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.12M	Buy	+26,400	New	+$3.05M	﹤0.01%	4651
2026 Q1	–	Sell	-5,600	Closed	-$763K	–	11266
2025 Q4	$763K	Hold	5,600	–	–	﹤0.01%	5800
2025 Q3	$826K	Buy	+5,600	New	+$777K	﹤0.01%	5722
2025 Q2	–	Sell	-4,400	Closed	-$526K	–	10910
2025 Q1	$526K	Buy	+4,400	New	+$545K	﹤0.01%	5818
2024 Q3	–	Sell	-11,200	Closed	-$1.52M	–	10138
2024 Q2	$1.52M	Buy	+11,200	New	+$1.52M	﹤0.01%	4032
2018 Q1	–	Sell	-35,700	Closed	-$2.44M	–	8217
2017 Q4	$2.44M	Buy	+35,700	New	+$2.37M	﹤0.01%	3022
2015 Q1	–	Sell	-100	Closed	-$4K	–	9466
2014 Q4	$4K	Buy	+100	New	+$3.66K	﹤0.01%	9136

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

UBS Group's XYL Position: Q2 2026 in Review

UBS Group increased its Xylem (XYL) stake by 33% in Q2 2026, buying an estimated $41.3M and bringing the position to 1,433,166 shares worth $169M. The position accounts for 0.02% of the portfolio, ranked #766.

UBS Group first reported a position in XYL in Q4 2014 and has held it in 47 quarters since. The position peaked at $235M in Q4 2024. 1,100 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

UBS Group held 1,433,166 shares of Xylem worth $169M as of Q2 2026.
UBS Group bought 358,083 Xylem shares in Q2 2026, an estimated $41.3M.
Xylem made up 0.02% of UBS Group's portfolio in Q2 2026, its #766 holding.
UBS Group first reported a position in Xylem in Q4 2014 and has held it in 47 quarters since.
UBS Group's Xylem position peaked at $235M in Q4 2024.
1,100 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.